Amgen Shares (Diluted) increased by 0.4% to 544M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.6%, from 541M to 544M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates potential dilution from employee compensation or convertible instruments, which can reduce earnings per share.
The weighted-average number of common shares outstanding plus the effect of all potentially dilutive securities, such as...
Standard metric for all public companies; essential for understanding the impact of equity-based compensation.
weighted_shares_diluted| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 576M | 570M | 551M | 537M | 538M | 538M | 537M | 538M | 536M | 541M | 542M | 541M | 541M | 542M | 544M |
| QoQ Change | — | -1.0% | -3.3% | -2.5% | +0.2% | +0.0% | -0.2% | +0.2% | -0.4% | +0.9% | +0.2% | -0.2% | +0.0% | +0.2% | +0.4% |
| YoY Change | — | — | — | -6.8% | -5.6% | -2.4% | +0.0% | +0.0% | -0.4% | +0.7% | +0.7% | +0.9% | +0.0% | +0.0% | +0.6% |